Advertisement

Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology)

      Modern cardiology has given up on curing heart disease. Its aggressive interventions—coronary artery bypass graft, atherectomy, angioplasty, and stenting—do not reduce the frequency of new heart attacks or prolong survival except in small subsets of patients.
      • Forrester J.S
      • Shah P.K
      Lipid lowering versus revascularization—an idea whose time for testing has come.
      For most patients these procedures do not treat life-threatening plaques.
      • Forrester J.S
      • Shah P.K
      Lipid lowering versus revascularization—an idea whose time for testing has come.
      ,
      • Ambrose J.A
      • Fuster V
      Can we predict future coronary events in patients with stable coronary artery disease?.
      Thus, it is clear that the goal of cardiology has become the relief of pain and unpleasant symptoms in the face of progressive disability and often death from disease. It is time to call this approach by its true name: palliative cardiology. It is also time to acknowledge that this approach is not the only alternative for our patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Forrester J.S
        • Shah P.K
        Lipid lowering versus revascularization—an idea whose time for testing has come.
        Circulation. 1997; 96: 1360-1362
        • Ambrose J.A
        • Fuster V
        Can we predict future coronary events in patients with stable coronary artery disease?.
        JAMA. 1997; 277: 343-344
        • Kesteloot H
        • Huang D.X
        • Yang X.S
        • Claes J
        • Rosseneu M
        • Geboers J
        • Joossens J.V
        Serum lipids in the People’s Republic of China. Comparison of Western & Eastern populations.
        Arteriosclerosis. 1985; 5: 427-433
        • Campbell T.C
        • Parpia B
        • Chen J
        Diet, lifestyle and the etiology of coronary artery disease.
        Am J Cardiol. 1998; 82: 18T-21T
        • Castelli W
        Take this letter to your doctor.
        Prevention. 1966; 48: 61-64
        • Castelli W.P
        • Doyle J.T
        • Gordon T
        • Hames C.G
        • Hjortland M.C
        • Hulley S.B
        • Kagan A
        • Zukel W.J
        HDL cholesterol and other lipids in coronary heart disease.
        Circulation. 1977; 55: 767-772
        • Blankenhorn D.H
        • Nessim H.A
        • Johnson R.L
        • Sanmarco M.E
        • Azen S.P
        • Cashan-Hempill L
        Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.
        JAMA. 1987; 257: 3233-3240
        • Gould A.L
        • Rossouw J.E
        • Santanello N.C
        • Heyse J.F
        • Furberg C.D
        Cholesterol reduction yields clinical benefit. A new look at old data.
        Circulation. 1995; 91: 2274-2282
        • Downs J.R
        • Clearfield M
        • Weis S
        • Whitney E
        • Shapiro D.R
        • Beere P.A
        • Langendorfer A
        • Stein E.A
        • Kruyer W
        • Gotto Jr, A.M
        Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. The Air Force/Texas Coronary Atherosclerosis Prevention Study.
        JAMA. 1998; 279: 1615-1622
        • Braunwald E
        Shattuck lecture.
        N Engl J Med. 1997; 337: 1360-1369
        • Tu J.V
        • Pashos C.L
        • Naylor C.D
        • Chen E
        • Normand S.L
        • Newhouse J.P
        • McNeil B.J
        Use of cardiac procedures and outcomes in the elderly patients with myocardial infarction in the United States and Canada.
        N Engl J Med. 1997; 336: 1500-1505
        • Bypass Angioplasty Revascularization Investigation (BARI) Investigators
        Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.
        N Engl J Med. 1996; 335: 217-225
        • Topol E.J
        Coronary artery stents—gauging, gorging, and gouging.
        N Engl J Med. 1998; 339: 1702-1703
        • Esselstyn Jr, C.B
        • Ellis S.G
        • Medendorp S.V
        • Crowe T.D
        A strategy to arrest and reverse coronary artery disease.
        J Fam Prac. 1995; 41: 560-568
        • Roberts W.C
        Atherosclerotic risk factors—are there ten or is there only one?.
        Am J Cardiology. 1989; 64: 552-554
        • Ornish D
        • Brown S.E
        • Scherwitz L.W
        • Billings J.H
        • Armstrong W.T
        • Ports T.A
        • McLanahan S.M
        • Kirkeeide R.L
        • Brand R.J
        • Gould K.L
        Can lifestyle changes reverse coronary artery disease? The Lifestyle Heart Trial.
        Lancet. 1990; 336: 129-133
        • Watts G.F
        • Lewis B
        • Brunt J.N
        • Lewis E.S
        • Coltart D.J
        • Smith L.D
        • Mann J.I
        • Swan A.V
        Effects on coronary artery disease of lipid lowering diet, or diet plus cholestyramine, in the St. Thomas’ Atherosclerotic Regression Study (STARS).
        Lancet. 1992; 339: 563-569
        • Ornish D
        • Scherwitz L.W
        • Billings J.H
        • Gould K.L
        • Merritt T.A
        • Sparler S
        • Armstrong W.T
        • Ports T.A
        • Kirkeeide R.L
        • Hogeboom C
        • Brand R.J
        Intensive lifestyle changes for reversal of coronary heart disease.
        JAMA. 1998; 280: 2001-2007
        • Lichtenstein A.H
        • Van Horn L
        Very low fat diets.
        Circulation. 1998; 98: 935-939
        • National Research Council (US) Committee on Diet & Health
        Diet and health. National Academy Press, Washington, DC1989